Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

Ever woken up multiple times at night, groggy and frustrated, just to rush to the bathroom? You might blame your bladder, or ...

Two Atlanta-area prostate cancer survivors are joining forces to share their stories in an effort to help others. Ernie ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has emerged over the past two decades.

Staying on top of your health isn’t just about hitting the gym, eating well, or getting the necessary vaccines. It also means ...

A new article published in Nature Medicine has shown how a new AI model can be used to predict future disease risk, including ...

-- BI 765423 has been developed to target IL-11, a key driver of fibrosis -- New study will investigate potential of BI 765423 to improve lung function for patients with idiopathic pulmonary fibrosis ...